Table 2.

Study data sources including data collector, data collection method, correlation to specific CFIR domain, and target study participant. Matrix of data collection methods

Type of data	Data collectors	Data collection method	CFIR domain	Study participants
Primary data	BHAP core team	Hospital assessment questionnaire	Inner setting	Pilot center physician champion
	St. Jude research team	Provider knowledge assessment	Inner setting	Multidisciplinary pilot center providers
		Organization Readiness for Implementing Change (ORIC)	Intervention characteristics	Pilot center implementation team
		Implementation Climate Scale (ICS)	Inner setting	Pilot center implementation team
		Complexity of intervention assessment	Intervention characteristics	Pilot center implementation team
		Implementation outcome surveys (Feasibility of Intervention Measure, Acceptability of Intervention Measure, Intervention Appropriateness Measure)	Intervention characteristics	Pilot center implementation team
		Strategy ranking survey	Process	Pilot center implementation team
		Stakeholder interviews (barrier assessment, informed adaptation of patient eligibility criteria and training materials, strategy prioritization, and assessment)	Inner setting Process Intervention characteristics Outer setting	Key stakeholders
		Meeting notes	Process	Key stakeholders
		Group interview (strategy analysis, feedback on training strategy, implementation outcome, team dynamics, identifying unanticipated challenges, and adaptation of implementation, provider satisfaction)	Inner setting Process Intervention characteristics	Pilot center implementation team
Secondary data	Local site providers	Medication interruption record	Intervention characteristics	Blinatumomab recipients
	Local site providers	Adverse event reporting, severity, and number of events	Intervention characteristics	Blinatumomab recipients
	Local site providers	Disease outcomes (MRD status, remission status, proceed to transplant, mortality)	Intervention characteristics	Blinatumomab recipients
	Local site providers	Participant satisfaction	Intervention characteristics	Patient and family
	Local site providers	Baseline patient characteristics	Intervention characteristics Inner setting	Blinatumomab recipients
	Local site providers	Delivery cost of blinatumomab	Intervention characteristic	Blinatumomab recipients
Process indicators	St. Jude research team	Attendance of training sessions, utilization of web-based resources, and proportion of patients enrolled in the BHAP program	Process	Pilot center providers

BHAP Blincyto® Humanitarian Access Program, CFIR Consolidated Framework for Implementation Research, MRD Minimal residual disease